Navigation Links
Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare Spending
Date:3/25/2013

MOUNTAIN VIEW, Calif., March 25, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq:   VVUS) announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

The study, conducted by Kenneth E. Thorpe , PhD, Professor and Chair, Department of Health Policy and Management, Rollins School of Public Health, Emory University, was published today online [http://www.healtheconomicsreview.com/content/pdf/2191-1991-3-7.pdf] in Health Economics Review. It is the first research to project the potential impact that a new generation of FDA-approved anti-obesity medications could have on Medicare spending among adults aged 65 and older who are either obese or overweight with at least one weight-related comorbidity such as hypertension or diabetes.

"America's weight problem is contributing to its spending problem," said Dr. Thorpe. "Including anti-obesity medications that can achieve this level of efficacy in the Medicare benefits package will fill the gap between lifestyle changes alone and bariatric surgery. It could save billions in lifetime Medicare spending."

"Obesity is a chronic condition that contributes to a number of comorbidities such as diabetes and hypertension, which are costly to treat," said W. Timothy Garvey , MD, Butterworth Professor and Chair, Department of Nutrition Sciences at the University of Alabama at Birmingham. "By targeting obesity as a key contributor to these conditions, we can improve patient outcomes and make a positive impact on the costs related to treating these comorbiditi
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
2. New analysis by West Health Institute finds medical device interoperability could save more than $30 billion a year
3. Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012
4. Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
5. The Top 100 Distributors of IVD Reagents, Instruments & Accessories in Europe 2012 Report Available Now for Analysis
6. Fluidigm Due Diligence: Company SWOT Analysis and Market Opportunity 2012
7. Timely Analysis of Pain Relief Costs and Outcomes Finds Disproportionate Risks for Seniors
8. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
9. Analysis of the U.S. Neurostimulation Market
10. New Analysis Shows Age has a Significant Effect on Outcomes in Patients Being Treated for Clostridium difficile Infection (CDI)
11. Radiation Detection, Monitoring & Safety Market (Geiger Counter, Ionization Chamber, Scintillator, Terahertz detector, Dosimeter, Environment Monitor, Shield, Lead Apron, Eyewear & Glove) - Competitive Analysis & Global Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Top-line Data Expected in August -, EXTON, ... today the completion of the pivotal efficacy portion ... Isolagen,Therapy(TM) for the treatment of nasolabial folds, or ... the primary efficacy follow-up visit,and collation of this ...
... ... Professionals, VOORHEES, N.J., July 1 ... a wide spectrum of,severity, ranging from mild diarrhea to pseudomembranous colitis ... who develop an initial,case of CDI.(1) These patients are at increased ...
Cached Medicine Technology:Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2
(Date:6/30/2015)... ... 30, 2015 , ... Red Hot & Blue Restaurants, Inc. took ... http://scoutology.com/novaburgerwars and was selected as “Best BBQ” in a Texas-based Living ... Hot & Blue President Randy McCann said, “Everyone knows Red Hot & Blue serves ...
(Date:6/30/2015)... ... June 30, 2015 , ... After more than ... Food and Drug Administration, GlobalSun (TM) — sunscreen specifically formulated for the unique skin ... rating of 35, hits the market just in time to help protect the skin ...
(Date:6/30/2015)... ... 30, 2015 , ... James C. Wittig, MD , ... HackensackUMC and Director of the Skin and Sarcoma division at the John Theurer ... Orthopedic Oncology and Pathology Course. The newly installed lectures are designed to ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... alleging heart attack and stroke incidents are linked to testosterone replacement therapy announce ... Management Conference is scheduled for July 9, 2015, according to court documents.* The ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... announced today a partnership with Knockout Zone Miami (KO Zone), a ... and conditioning specialist and CrossFit Coach, Diego de Vera. The partnership will provide ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3
... honor of World TB Day 2008 (March 24), the ... Medicine Association (HIVMA) are urging U.S. policymakers to step ... against the disease both at home and abroad. , ... progress in detecting new cases on the decline, resources ...
... wearers are often warned to properly clean their lenses ... intense pain, and sight impairment. , Researchers from University ... School of Medicine have been awarded a $2.4 million ... (NEI) to study corneal infection (keratitis) brought on by ...
... At a conference with,security analysts today, DuPont ... Chief,Financial Officer Jeffrey L. Keefer reviewed the company,s ... growth rate over,the next three years., "As ... product innovation," Keefer said. "Our rising return from ...
... Bureau of TennCare and,Shared Health, Tennessee,s largest ... pilot program to introduce ePrescribing,capabilities to rural ... The ePrescribing program is a community approach ... patient care. Fifty rural,physician practices across 13 ...
... and wellness a priority at all,levels, staffing, products, ... 20 Blue Cross and Blue Shield,of Illinois ... spanning all aspects of the company,s business and ... health and wellness,of our members and our communities ...
... March 20 Alseres,Pharmaceuticals, Inc. (Nasdaq: ALSE ... Amended and Restated Convertible Promissory Note Purchase Agreement,dated ... Gipson, Thomas Gipson, Arthur,Koenig, Ingalls & Snyder Value ... The agreement provides for the Company to borrow,in ...
Cached Medicine News:Health News:ID, HIV experts urge more resources for TB 2Health News:$2.4 million grant for study of corneal infections associated with contact lenses 2Health News:DuPont Chief Financial Officer Reviews Company's Accelerated Growth Plan 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 3Health News:Blue Cross and Blue Shield of Illinois Evolves its Role, Commits to Health and Wellness of Members and Communities 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: